LF IV INJECTION

 

​LF IV contains S-enantiomer of levofloxacin .It belongs to fluoroquinolone antibiotic, which acts by inhibiting DNA gyrase thus initiates DNA breakage and thus prevent the bacterial infection. Its bioavailability is about 99%. It is indicated in Community acquired pneumonia, Complicated and Uncomplicated urinary tract infection, Nosocomial infections and Chronic bronchitis.

Product Category

ANTI-BIOTICS / ANTI-BACTERIAL

Product Specification

Product Description

​Levofloxacin 500 mg. per 100 ml. IV

Send Enquiry